Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
proteomics
MedTech
Thermo Fisher collects green lights for $3.1B Olink takeover
With a new go-ahead from antitrust regulators in the U.K., Thermo Fisher Scientific is on its way to closing its $3.1 billion deal for Olink.
Conor Hale
Jul 8, 2024 10:25am
Protein parser Alamar Bio collects $128M for analyzer launch
Mar 1, 2024 10:58am
NanoString loses $31M patent verdict to 10x Genomics
Nov 20, 2023 4:15pm
Bruker taps into single-cell biology with $108M PhenomeX deal
Aug 21, 2023 12:55pm
Bruker expands CRO plans with Biognosys majority ownership deal
Jan 4, 2023 3:15pm
Startup Pleno nabs $15M for telecom-based multiomics approach
May 25, 2022 9:00am
